Table 1.
Comparison of Adult LT Recipients With Cirrhosis Between Group A (15th March–10th June 2020) and Group B (15th March–10th June 2019)a.
| Parameter | Group A (n = 20) | Group B (n = 36) | P value |
|---|---|---|---|
| Age (years) of adult patients | 51.9 ± 10.8 | 48.4 ± 10.1 | 0.230 |
| Male: female (patients with cirrhosis) | 18:2 | 33:3 | 1.0 |
| CTP | 9.1 ± 2.0 | 9.0 ± 1.9 | 0.853 |
| CTP (n = 17 and 32, excluding transplants for mainly for HCC) | 9.7 ± 1.5 | 9.6 ± 1.3 | 0.795 |
| MELD | 17.9 ± 7.9 | 15.1 ± 5.9 | 0.138 |
| MELD (n = 17 and 32, excluding transplants for mainly for HCC) | 19.8 ± 7.0 | 16.1 ± 5.6 | 0.034 |
| Indication of liver transplantation | |||
| Decompensated cirrhosis ± HCC | 17 | 32 | |
| Child's A cirrhosis with HCC | 3 | 4 | 0.691 |
| Etiology of cirrhosis | |||
| Alcoholic liver disease: hepatitis C, hepatitis B: NASH/cryptogenic: others | 10:3:2:4:1 | 16:6:4:9:1 | 0.979 |
CTP: Child–Turcotte–Pugh score; HCC: hepatocellular carcinoma; MELD: model for end-stage liver disease score, NASH: non-alcoholic steatohepatitis related.
a
After exclusion of pediatric patients (n = 3), patients with acute liver failure (n = 2) and combined kidney liver transplantation (n = 1).